InsidersTradesSigma
Follow the 메디톡스 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 메디톡스 has recorded 6 public disclosures. Market capitalisation: €468bn. The latest transaction was disclosed on 7 July 2026 (Purchase). Among the most active insiders: 정현호. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Medytox is a company specializing in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development of innovative biopharmaceutical products.